With FDA Approval and Pfizer Deal in Hand, Myovant Appoints New CEO

cafead

Administrator
Staff member
  • cafead   Jan 04, 2021 at 11:12: PM
via After guiding Myovant to a successful FDA approval and inking a $4.2 billion deal with pharma giant Pfizer, Chief Executive Officer (CEO) Lynn Seely is bowing out to make room for the next chief, David Marek.

article source
 

<